Health tech

Health Tech Newsletter Mohana Ravindranath

STAT Plus: Pfizer, Eli Lilly execs push back as senators scrutinize drugmakers’ telehealth moves

First Opinion Ashten Duncan, Khuzeman Abbasi, and Sana Augustine

STAT Plus: The invisible wasteland of health care data

Health tech Brittany Trang

STAT Plus: Using AI to design small molecule drugs is tough. Here are five companies trying to crack the code

Health tech Nicholas St. Fleur

STAT Plus: What YouTube Health is doing to combat misinformation and promote evidence-based content

Exclusive Allison DeAngelis

STAT Plus: Recursion, the AI drug development company, cuts more jobs after finalizing Exscientia merger

Health Tech Newsletter Brittany Trang

STAT Plus: Why AI may not help decrease radiologists’ burnout

Health tech Brittany Trang

STAT Plus: Government watchdog calls out HHS for not auditing health care’s privacy compliance since 2017

Health tech Casey Ross, Katie Palmer, and Brittany Trang

STAT Plus: Regulating generative AI: FDA’s challenges laid bare by digital health advisory committee

Health Tech Newsletter Mario Aguilar

STAT Plus: FDA chief: AI adoption driven by financial reasons, not patient benefits

Health tech Katie Palmer

STAT Plus: Bluesky is the new destination for X/Twitter’s health and science community. Here’s why

Health tech Brittany Trang

STAT Plus: AI in drug discovery is ‘nonsense,’ but call Schrödinger ‘AI’ if you want, says CEO

Health tech Lizzy Lawrence

STAT Plus: New details on a risky medical device show need for more FDA transparency, researchers say

Health tech Timmy Broderick

STAT Plus: AI-guided decisions can devastate lower-income Americans. This group wants to change that

Health tech Brittany Trang

STAT Plus: Why the crowded market for ambient AI medical scribes might be ripe for consolidation

Health tech Katie Palmer and Casey Ross

STAT Plus: In first meeting of FDA’s digital health advisory committee, generative AI is up for debate

Health tech Mario Aguilar and Katie Palmer

STAT Plus: Stalemate breaks on telehealth prescriptions of stimulants and addiction treatment 

First Opinion Walter G. Johnson

STAT Plus: Congress must act now to protect the future of diagnostic tests

Health Tech Newsletter Mario Aguilar

STAT Plus: A telehealth friend in the new Congress, and Amazon’s smile on a mental health service

Health tech Jon Chesto — Boston Globe

STAT Plus: Buoyed by billion-dollar deals, its stock is up 50% this year. How did Boston Scientific get its mojo back?

Health tech Mario Aguilar

STAT Plus: How Pfizer used wearables to tap into the promise of an experimental drug

Health tech Mohana Ravindranath

STAT Plus: OpenAI isn’t built for health care. So why is its tech already in hospitals, pharma, and cancer care?

Biotech Matthew Herper

STAT Plus: The end of 23andMe’s drug discovery dream

Exclusive Katie Palmer

STAT Plus: Children’s Hospital Los Angeles tests generative AI to translate discharge notes into Spanish

Health tech Casey Ross and Mario Aguilar

STAT Plus: How Trump’s approach to regulating AI in health care could diverge from Biden’s

Who to Know Katie Palmer

STAT Plus: These 6 companies are using AI to streamline clinical trials for pharma

Who to Know Brittany Trang

STAT Plus: 7 companies to watch in AI protein design

Health tech Mario Aguilar

STAT Plus: Medicare finalized coverage for some mental health apps. Now what?

Health Tech Newsletter Mario Aguilar

STAT Plus: Oracle reveals new AI-powered EHR, insights from telehealth earnings, and more

Health tech Mario Aguilar

STAT Plus: Apple claims new AirPod hearing aid feature is ‘clinical grade.’ Is it?